Mr Robert Puopolo > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Mr Robert Puopolo
Position
Partner
Career
Rob Puopolo, a partner in Goodwin’s Life Sciences group, focuses his practice on representing public and privately held life sciences companies, as well as the venture capital firms, investment banks and hedge funds that focus on these companies.
Rob also serves on many committees within Goodwin’s Life Sciences business unit, including: the European Committee, the Capital Markets Committee, and the Diversity, Equity + Inclusion committee, through which he serves as a mentor to associates and junior partners and is an active advocate of the firm’s broader diversity and inclusion efforts.
Education
J.D., 1998 Suffolk University School of Law (cum laude) / B.A., 1993 Northeastern University
Lawyer Rankings
United States > Healthcare > Life sciences
(Next Generation Partners)Goodwin’s life sciences team assist a diverse roster of pharmaceutical companies – both public and private – and life science venture capital firms. Mitchell Bloom and Kingsley Taft jointly lead the team; Taft primarily advises life sciences companies throughout their life cycles on formation, venture financings, and IPOs, while Bloom is active in the biotechnology and medical IT spaces. Boston-based Robert Puopolo maintains a transactions focused practice, handling joint ventures and life sciences M&A. In San Francisco, Alexander Varond takes the lead on litigious matters concerning biosimilars and the Hatch-Waxman Act. Stuart Cable is particularly adept at advising on corporate governance and venture sourced investment, while Danielle Lauzon assists boards and management teams of therapeutics and bioscience companies. A large team including Philadelphia-based Rachael Bushey, who specializes in transactional and governance work in the pharma and biotech space, joined the firm from Troutman Pepper in January 2023. All named practitioners are based in Boston unless specified otherwise.
Lawyer Rankings
- Next Generation Partners United States > Healthcare > Life sciences
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)